2023中國非主板(ban)(ban)上(shang)(shang)市(shi)公(gong)司百強排名榜(bang)(bang)，重點關注(zhu)科(ke)(ke)創(chuang)(chuang)和(he)專(zhuan)精特新類企(qi)(qi)(qi)(qi)業，涵(han)蓋創(chuang)(chuang)業板(ban)(ban)、科(ke)(ke)創(chuang)(chuang)板(ban)(ban)和(he)北(bei)交(jiao)(jiao)所(suo)全部上(shang)(shang)市(shi)公(gong)司，共有100家企(qi)(qi)(qi)(qi)業上(shang)(shang)榜(bang)(bang)，其中，52家企(qi)(qi)(qi)(qi)業同(tong)時進(jin)入(ru)2023年中國上(shang)(shang)市(shi)公(gong)司百強排行(xing)榜(bang)(bang)，相較去年增加12家，創(chuang)(chuang)業板(ban)(ban)企(qi)(qi)(qi)(qi)業有63家，科(ke)(ke)創(chuang)(chuang)板(ban)(ban)企(qi)(qi)(qi)(qi)業有35家，北(bei)交(jiao)(jiao)所(suo)企(qi)(qi)(qi)(qi)業有2家。

在2023中(zhong)國(guo)100強非(fei)主板上市公司排(pai)名(ming)中(zhong)，上榜企業(ye)的入圍門檻(jian)為2022年度利(li)潤總額9.02億元，寧(ning)德時代、大全能源、中(zhong)芯國(guo)際、邁瑞醫療、天華新(xin)能5家企業(ye)利(li)潤總額超過100億元，排(pai)名(ming)前5，安(an)旭(xu)生物、德方納米排(pai)名(ming)進(jin)步最多。